Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex

British Journal of Pharmacology

Volumn 117, Issue 5, 1996, Pages 931-937

  Obrenovitch, T P ^a   Zilkha, E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

d.c. potential; Focal ischaemia; L 701,324; Microdialysis electrode; Migraine; N methyl D aspartate receptor glycine site; Spreading depression

Indexed keywords

7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; POTASSIUM ION;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CEREBROSPINAL FLUID; DRUG POTENCY; ELECTROENCEPHALOGRAM; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SPREADING CORTICAL DEPRESSION;

EID: 0029981624     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15283.x     Document Type: Article

References (51)

1. BUREŠ, J., BURESOVÁ, O. & KŘIVÁNEK, J. (1974). The Mechanisms and Applications of Leão's Spreading Depression of Electroencephalographic Activity. New York: Academic Press.
2. CARLA, V. & MORONI, F. (1992). General anaesthetics inhibit the responses induced by glutamate receptor agonists in the mouse cortex. Neurosci. Lett., 146, 21-24.
3. CARTER, A.J. (1994). Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination. J. Pharmacol. Exp. Ther., 269, 573-580.
4. CROUCHER, M.J., COLLINS, J.P. & MELDRUM, B.S. (1982). Anticonvulsant action of excitatory amino acid antagonists. Science, 216, 899-902.
5. DUCKROW, R.B. (1991). Regional cerebral blood flow during cortical spreading depression in conscious rats. J. Cereb. Blood Flow Metab., 11, 150-154.
6. FIX, A.S., LONG, G.G., WOZNIAK, D.F. & OLNEY, J.W. (1994). Pathomorphologic effects of N-methyl-D-aspartate antagonists in the rat posterior cingulate/retrosplenial cerebral cortex: a review. Drug Develop. Res., 32, 147-152.
7. FOSTER, A.C. & WONG, E.H.F. (1987). The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Br. J. Pharmacol., 91, 403-409.
8. GARDNER-MEDWIN, A.R. (1981). Possible roles of vertebrate neuroglia in potassium dynamics, spreading depression and migraine. J. Exp. Biol., 95, 111-127.
9. HARGREAVES, R.J., RIGBY, M., SMITH, D. & HILL, R.G. (1993). Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), and NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology. Br. J. Pharmacol., 110, 36-42.
10. HERNÁNDÉZ-CÁCERES, J., MARIA-CONZÁLEZ, R., BROZEK, G. & Š, J. (1987). Systemic-ketamine blocks cortical spreading depression but does not delay the onset of terminal anoxic depolarization in rats. Brain Res., 437, 360-364.
11. + in hippocampus of anesthetized rats. Brain Res., 610, 283-294.
12. HUETTNER, J.R. & BEAN, B.P. (1988). Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc. Natl. Acad. Sci. U.S.A., 85, 1307-1311.
13. IIJIMA, T., MIES, G. & HOSSMANN, K-A. (1992). Repeated negative DC deflections in rat cortex following middle cerebral artery occlusion are abolished by MK-801: Effect on volume of ischemic injury. J. Cereb. Blood Flow Metab., 12, 727-733.
14. KARI, P.H. & VYAS, K.P. (1994). The physiological disposition of L-701,324 (I), a selective glycine/N-methyl-D-aspartate receptor antagonist, in the rat, dog and chimpanzee. Pharmacol. Res., 11 (Suppl), S346.
15. KOEK, W. & COLPAERT, F.F. (1990). Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: Relationship with phencyclidine-like behavioral effects. J. Pharmacol. Exp. Ther., 252, 349-357.
16. KULAGOWSKI, J.J., BAKER, R., CURTIS, N.R., LEESON, P.D., MAWER, I.M., MOSELEY, A.M., RIDGILL, M.P., ROWLEY, M., STANSFIELD, I., FOSTER, A.C., GRIMWOOD, S., HILL, R.G., KEMP, J.A., MARSHALL, G.R., SAYWELL, K.L. & TRICKLEBANK, M.D. (1994). 3′-(arylmethyl)- and 3′-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: Orally active antagonists of the glycine site on the NMDA receptor. J. Med. Chem., 37, 1402-1405.
17. 2 response. J. Cereb. Blood Flow Metab., 4, 546-554.
18. LAURITZEN, M. (1994). Pathophysiology of the migraine aura: the spreading depression theory. Brain 117, 199-210.
19. LAURITZEN, M. & HANSEN, A.J. (1992). The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J. Cereb. Blood Flow Metab., 12, 223-229.
20. LEÃOS, A.A.P. (1944). Further observations on spreading depression of activity in the cerebral cortex. J. Neurophysiol., 7, 359-390.
21. LEESON, P.D. & IVERSEN, L.L. (1994). The glycine site of the NMDA receptor: Structure-activity relationship and therapeutic potential. J. Med. Chem., 37, 4053-4067.
22. 2 and hyperventilation on spreading depression in the rat. Arch. Int. Physiol. Biochem., 94, 19-20.
23. MARRANNES, R., WILLEMS, R., DE PRINS, E. & WAUQUIER, A. (1988). Evidence fora role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res., 457, 226-240.
24. 3H]MK-801 binding and reversal by glycine. Neurosci. Lett., 132, 73-76.
25. MARTIN, D.C., PLAGENHOEF, M., ABRAHAM, J., DENNISON, R.L. & ARONSTAM, R.S. (1995). Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors. Biochem. Pharmacol., 49, 809-817.
26. MARTIN, H., WARNER, D.S. & TODD, M.M. (1994). Effects of glycine receptor antagonism on spreading depression in the rat. Neurosci. Lett., 180, 285-289.
27. MAYEVSKY, A., DORON, A., MANOR, T., MEILIN, S., SALAME, K. & OUAKNINE, G.E. (1995). Repetitive cortical spreading depression cycle development in the human brain: a multiparametric monitoring approach. J. Cereb. Blood Flow Metab., 15 (Suppl.1), S34.
28. MCFARLANE, C., WARNER, D.S., NADER, A. & DEXTER, F. (1995). Glycine receptor antagonism. Effects of ACEA-1021 on the minimum alveolar concentration for halothane in rats. Anesthesiology, 82, 963-968.
29. MUTCH, W.A.C. & HANSEN, A.J. (1984). Extracellular pH changes during spreading depression and cerebral ischemia: mechanisms of brain pH regulation. J. Cereb. Blood Flow Metab., 4, 17-27.
30. OBRENOVITCH, T.P. (1995). The ischaemic penumbra: twenty years on. Cerebrovasc. Brain Metab. Rev., 7, (in press).
31. OBRENOVITCH, T.P., HARDY, A.M. & ZILKHA, E. (1996). Effects of L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate (NMDA) receptor, on the electroencephalogram and NMDA- evoked responses in the rat striatum. Br. J. Pharmacol., (in press).
32. OBRENOVITCH, T.P., MATSUMOTO, T. & SYMON, L. (1989). Multiparametric monitoring of the rat cerebral cortex subjected to transient ischemia: a powerful tool for assessing 'antiischemic' drugs. J. Cereb. Blood Flow Metabol., 9 (S 1), S630.
33. OBRENOVITCH, T.P., RICHARDS, D.A., SARNA, G.S. & SYMON, L. (1993). Combined intracerebral microdialysis and electrophysiological recording: Methodology and applications. J. Neurosci. Methods, 47, 139-145.
34. OBRENOVITCH, T.P., URENJAK, J. & ZILKHA, E. (1994). Intracerebral microdialysis combined with recording of extracellular field potential: a novel method for investigation of depolarizing drugs in vivo. Br. J. Pharmacol., 113, 1295-1302.
35. OBRENOVITCH, T.P. & ZILKHA, E. (1995). High extracellular potassium, and not extracellular glutamate, is required for the propagation of spreading depression. J. Neurophysiol., 73, 2107-2114.
36. OBRENOVITCH, T.P., ZILKHA, E. & URENJAK, J. (1995). Intracerebral microdialysis: Electrophysiological evidence of a critical pitfall. J. Neurochem., 64, 1884-1887.
37. PATEL, P.M., DRUMMOND, J.C., COLE, D.J. & KELLY, P. (1995). Effect of isoflurane on NMDA-induced spreading depression in rats. Anesth. Analg., 80, S372.
38. PIPER, R.D., LAMBERT, G.A. & MICHALICEK, J. (1991). Inhalational anesthetic agents decrease susceptibility to cortical spreading depression in the cat. Soc. Neurosci. Abstr., 17, 339.9.
39. PRIESTLEY, T., DANKS, P., MARSHALL, G.R., KEMP, J.A., KULAGOWSKI, J., LEESON, P.D. & HILL, R.G. (1994). L-701,324: a high affinity antagonist at the glycine-recognition site of the NMDA receptor. Br. J. Pharmacol., 113, 31P.
40. PUIL, E. & EL-BEHEIRY, H. (1990). Anaesthetic suppression of transmitter actions in neocortex. Br. J. Pharmacol., 101, 61-66.
41. REID, K.H., MARRANNES, R. & WAUQUIER, A. (1988). Spreading depression and central nervous system pharmacology. J. Neurosci., 19, 1-21.
42. SAITO, R., GRAF, R., ROSNER, G., HÜBEL, K., TAGUCHI, G. & HEISS, W.-D. (1993). Anesthesia affects potassium evoked spreading depression in cats. J. Cereb. Blood Flow Metab., 13 (Suppl. 1), S86.
43. SAYWELL, K., BRISTOW, L.J., FOSTER, A.C., GRIMWOOD, S., HILL, R.G., HUTSON, P.H., KULAGOWSKI, J., LEESON, P.D. & TRICKLEBANK, M.D. (1995). The pharmacological profile of the glycine/NMDA receptor antagonist, L-701,324. Br. J. Pharmacol., 114, 320P.
44. SHEARDOWN, M.J. (1993). The triggering of spreading depression in the chicken retina; a pharmacological study. Brain Res., 607, 189-194.
45. +: role of glia. Brain Res., 542, 259-265.
46. +-induced depolarisation in the rat striatum. J. Neurochem., 62, 2368-2374.
47. VERHAEGEN, M., TODD, M.M. & WARNER, D.S. (1992). The influence of different concentrations of volatile anesthetics on the threshold for cortical spreading depression in rats. Brain Res., 581, 153-155.
48. WARNER, D.S., MARTIN, H., LUDWIG, P., MCALLISTER, A., KEANA, J.F.W. & WEBER, E. (1995). In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists. J. Cereb. Blood Flow Metab., 15, 188-196.
49. WILLETTS, J., BALSTER, R.L. & LEANDER, J.D. (1990). The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol. Sci., 11, 423-428.
50. WONG, E.H.F., KEMP, J.A., PRIESTLEY, T., KNIGHT, A.R., WOODRUFF, G.N. & IVERSEN, L.L. (1986). The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. U.S.A., 83, 7104-7108.
51. WOODWARD, R., HUETTNER, J., GUASTELLA, J., KEANA, J.F. & WEBER, E. (1995). In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Mol. Pharmacol., 47, 568-581.